Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data

• Published in: Critical care (London, England) England), 2012-10, Vol.16 (5), p.R175-R175, Article R175
• Main Authors: Brunner, Richard, Adelsmayr, Gabriel, Herkner, Harald, Madl, Christian, Holzinger, Ulrike
• Format: Article
• Language: English
• Subjects: Aged; Algorithms; Analysis; Blood Glucose - metabolism; Blood sugar; Blood sugar monitoring; Care and treatment; Computer Systems - trends; Critical Illness - mortality; Critical Illness - therapy; Diabetes; Diabetes therapy; Diabetics; Female; Glucose monitors; Glycemic index; Glycemic Index - physiology; Health aspects; Humans; Male; Middle Aged; Mortality; Mortality - trends; Prospective Studies; Retrospective Studies; Statistics as Topic - trends
• ISSN: 1364-8535; 1466-609X; 1364-8535
• DOI: 10.1186/cc11657

Glycemic variability as a marker of endogenous and exogenous factors, and glucose complexity as a marker of endogenous glucose regulation are independent predictors of mortality in critically ill patients. We evaluated the impact of real time continuous glucose monitoring (CGM) on glycemic variability in critically ill patients on intensive insulin therapy (IIT), and investigated glucose complexity--calculated using detrended fluctuation analysis (DFA)--in ICU survivors and non-survivors. Retrospective analysis were conducted of two prospective, randomized, controlled trials in which 174 critically ill patients either received IIT according to a real-time CGM system (n = 63) or according to an algorithm (n = 111) guided by selective arterial blood glucose measurements with simultaneously blinded CGM for 72 hours. Standard deviation, glucose lability index and mean daily delta glucose as markers of glycemic variability, as well as glucose complexity and mean glucose were calculated. Glycemic variability measures were comparable between the real time CGM group (n = 63) and the controls (n = 111). Glucose complexity was significantly lower (higher DFA) in ICU non-survivors (n = 36) compared to survivors (n = 138) (DFA: 1.61 (1.46 to 1.68) versus 1.52 (1.44 to 1.58); P = 0.003). Diabetes mellitus was significantly associated with a loss of complexity (diabetic (n = 33) versus non-diabetic patients (n = 141) (DFA: 1.58 (1.48 to 1.65) versus 1.53 (1.44 to 1.59); P = 0.01). IIT guided by real time CGM did not result in significantly reduced glycemic variability. Loss of glucose complexity was significantly associated with mortality and with the presence of diabetes mellitus.